Discrepancies between ClinicalTrials.gov recruitment status and actual trial status: a cross-sectional analysis
暂无分享,去创建一个
Timothy F Platts-Mills | Christopher W. Jones | T. Platts-Mills | Christopher W Jones | Michelle R Safferman | Amanda C Adams
[1] Christopher W. Jones,et al. Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis , 2014, Systematic Reviews.
[2] Thomas J. Smith,et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] David Moher,et al. Comparison of registered and published primary outcomes in randomized controlled trials. , 2009, JAMA.
[4] Christopher W. Jones,et al. Non-publication of large randomized clinical trials: cross sectional analysis , 2013, BMJ.
[5] Harlan M. Krumholz,et al. Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis , 2009, PLoS medicine.
[6] J.,et al. The New England Journal of Medicine , 2012 .
[7] P. Santaguida,et al. Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines , 2009, Journal of Neuro-Oncology.
[8] Phil Edwards,et al. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.
[9] Dean A Fergusson,et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. , 2013, JAMA.
[10] Harlan M Krumholz,et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.
[11] James Topping,et al. Compliance with results reporting at ClinicalTrials.gov. , 2015, The New England journal of medicine.
[12] D. Matthews,et al. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[13] B. Levy,et al. Systemic therapy for small cell lung cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.
[14] Tony Tse,et al. Update on Trial Registration 11 Years after the ICMJE Policy Was Established. , 2017, The New England journal of medicine.
[15] P. Ravaud,et al. Characteristics and Public Availability of Results of Clinical Trials on Rare Diseases Registered at Clinicaltrials.gov. , 2016, JAMA internal medicine.
[16] J. Lindh,et al. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2013, PloS one.
[17] D. Grobbee,et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis , 2010, The Lancet.
[18] Timothy F. Platts-Mills,et al. Comparison of registered and published outcomes in randomized controlled trials: a systematic review , 2015, BMC Medicine.
[19] Ben Goldacre,et al. The TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions , 2016, F1000Research.
[20] Isabelle Boutron,et al. Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals , 2013, PLoS medicine.
[21] G. Guyatt,et al. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies , 2014, BMJ : British Medical Journal.